- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Intermagnetics names new CEO
MRI magnet supplier Intermagnetics General (IGC) of Latham, NY, in May appointed a new CEO to its management team. Effective June 1, Glenn Epstein replaced Carl Rosner, who announced that he would retire from the company at the end of fiscal 1999.
MRI magnet supplier Intermagnetics General (IGC) of Latham, NY, in May appointed a new CEO to its management team. Effective June 1, Glenn Epstein replaced Carl Rosner, who announced that he would retire from the company at the end of fiscal 1999. Epstein joined Intermagnetics in 1997, and has served as president and chief operating officer. He will retain his duties as president in his new post, and Rosner will continue as chairman of Intermagnetics board of directors.
In other Intermagnetics news, the company last month completed the acquisition of the manufacturing rights and licenses of Belfort, France-based Alstom-Intermagnetics (AISA), formerly a joint venture that Intermagnetics held with Alstom S.A. The deal includes capital equipment, inventory, and intellectual property, and was estimated at approximately $9 million.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
